Myostatin, a Negative Regulator of Muscle Growth, Functions by Inhibiting Myoblast Proliferation
Open accessThe DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Abstract
Myostatin, a member of the transforming growth factor-beta (TGF-beta) superfamily, has been shown to be a negative regulator of myogenesis. Here we show that myostatin functions by controlling the proliferation of muscle precursor cells. When C(2)C(12) myoblasts were incubated with myostatin, proliferation of myoblasts decreased with increasing levels of myostatin. Fluorescence-activated cell sorting analysis revealed that myostatin prevented the progression of myoblasts from the G(1)- to S-phase of the cell cycle. Western analysis indicated that myostatin specifically up-regulated p21(Waf1, Cip1), a cyclin-dependent kinase inhibitor, and decreased the levels and activity of Cdk2 protein in myoblasts. Furthermore, we also observed that in myoblasts treated with myostatin protein, Rb was predominately present in the hypophosphorylated form. These results suggests that, in response to myostatin signaling, there is an increase in p21 expression and a decrease in Cdk2 protein and activity thus resulting in an accumulation of hypophosphorylated Rb protein. This, in turn, leads to the arrest of myoblasts in G(1)-phase of cell cycle. Thus, we propose that the generalized muscular hyperplasia phenotype observed in animals that lack functional myostatin could be as a result of deregulated myoblast proliferation.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Myostatin is a cytokine that works by inhibiting the proliferation of satellite cells and the differentiation of myoblasts [10], while also decreasing adipogenesis via reductions in the secretion of leptin [11].”
From Effects of methoxyisoflavone, ecdysterone, and sulfo-polysaccharide supplementation on training adaptations in resistance-trained males (2006) · cites this paper as [10]
Citations
Cites
CDK inhibitors: positive and negative regulators of G1-phase progression
Sherr, C. J., & Roberts, J. M. (1999) · Genes & Development · doi:10.1101/gad.13.12.1501 · Cited by 6,115
Regulation of skeletal muscle mass in mice by a new TGF-p superfamily member
McPherron, A. C., Lawler, A. M., & Lee, S.-J. (1997) · Nature · doi:10.1038/387083a0 · Cited by 4,013
Inhibitors of mammalian G1 cyclin-dependent kinases.
Sherr, C. J., & Roberts, J. M. (1995) · Genes & Development · doi:10.1101/gad.9.10.1149 · Cited by 3,243
G1 phase progression: Cycling on cue
Sherr, C. J. (1994) · Cell · doi:10.1016/0092-8674(94)90540-1 · Cited by 2,674
Serial passaging and differentiation of myogenic cells isolated from dystrophic mouse muscle
YAFFE, D., & SAXEL, O. (1977) · Nature · doi:10.1038/270725a0 · Cited by 2,123
Double muscling in cattle due to mutations in the myostatin gene
McPherron, A. C., & Lee, S.-J. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.23.12457 · Cited by 2,039
pl5INK4B is a potentia| effector of TGF-β-induced cell cycle arrest
Hannon, G. J., & Beach, D. (1994) · Nature · doi:10.1038/371257a0 · Cited by 1,950
MyoD or Myf-5 is required for the formation of skeletal muscle
Rudnicki, M. A., Schnegelsberg, P. N. J., Stead, R. H., Braun, T., Arnold, H.-H., & Jaenisch, R. (1993) · Cell · doi:10.1016/0092-8674(93)90621-v · Cited by 1,731
A deletion in the bovine myostatin gene causes the double–muscled phenotype in cattle
Grobet, L., Royo Martin, L. J., Poncelet, D., Pirottin, D., Brouwers, B., Riquet, J., Schoeberlein, A., Dunner, S., Ménissier, F., Massabanda, J., et al. (1997) · Nature Genetics · doi:10.1038/ng0997-71 · Cited by 1,556
New functional activities for the p21 family of CDK inhibitors.
LaBaer, J., Garrett, M. D., Stevenson, L. F., Slingerland, J. M., Sandhu, C., Chou, H. S., Fattaey, A., & Harlow, E. (1997) · Genes & Development · doi:10.1101/gad.11.7.847 · Cited by 1,402
Research works printed but not linked: 1
- Ji, 1998, Am. J. Physiol., 275(4 Pt 2),, R1265
Cited by
Items 201–300 of 1,000
Myostatin in Muscle Growth and Repair
Sharma, M., Langley, B., Bass, J., & Kambadur, R. (2001) · Exercise and Sport Sciences Reviews · doi:10.1097/00003677-200110000-00004 · Cited by 84
“It is synthesized as a precursor form that is proteolytically processed to give rise to either 26-kDa or 12-kDa active processed mature myostatin in myoblasts or fibroblasts, respectively (Figure 2) (13).”
BackgroundInfluentialSelf-citationSignalling and the control of skeletal muscle size
Otto, A., & Patel, K. (2010) · Experimental Cell Research · doi:10.1016/j.yexcr.2010.04.009 · Cited by 100
Enhancement of meat production by environmental manipulations in embryo and young broilers
Halevy, O., Yahav, S., & ROZENBOIM, I. (2006) · World s Poultry Science Journal · doi:10.1017/s0043933906001103 · Cited by 103
“Myostatin is a member of the transforming growth factor-beta (TGF-β) super-family that inhibits satellite cell proliferation and differentiation (Thomas et al., 2000; Joulia et al., 2003) by World’s Poultry Science Journal, Vol. 62, September 2006 489 maintaining them in their quiescent state…”
BackgroundAbati, E., Manini, A., Comi, G. P., & Corti, S. P. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04408-w · Cited by 91
Adipogenic and myogenic gene expression in rotator cuff muscle of the sheep after tendon tear
Frey, E., Regenfelder, F., Sussmann, P. S., Zumstein, M. A., Gerber, C., Born, W., & Fuchs, B. (2008) · Journal of Orthopaedic Research® · doi:10.1002/jor.20695 · Cited by 84
Rossi, G., Antonini, S., Bonfanti, C., Monteverde, S., Vezzali, C., Tajbakhsh, S., Cossu, G., & Messina, G. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.02.014 · Cited by 81
“…regulates the balance be- tween proliferation and differentiation of muscle progenitors (Manceau et al., 2008), whereas in the adult, opposing roles in regulating myogenic differentiation have been reported (Langley et al., 2002; Thomas et al., 2000; McCroskery et al., 2003; Taylor et al., 2001).”
BackgroundRole of growth differentiation factor 11 in development, physiology and disease
Zhang, Y., Wei, Y. S., Liu, D., Liu, F., Li, X. A., Pan, L., Pang, Y., & Chen, D. (2017) · Oncotarget · doi:10.18632/oncotarget.20258 · Cited by 88
“GDF8, a secreted protein that is highly related to GDF11, is a known regulator to inhibit skeletal muscle development [44].”
BackgroundPotential Adverse Effects of Dexamethasone Therapy on COVID-19 Patients: Review and Recommendations
Chen, F., Hao, L., Zhu, S., Yang, X., Shi, W., Zheng, K., Wang, T., & Chen, H. (2021) · Infectious Diseases and Therapy · doi:10.1007/s40121-021-00500-z · Cited by 86
“observed that the upregulation of myostatin gene expression caused by dexamethasone was associated with the myostatin gene promoter and glucocorticoid responsive element along the promoter [73], and the increased myostatin led to the changes in ultrastructure of skeletal muscle, including the inhibition of myoblast pr…”
BackgroundMatsakas, A., Foster, K., Otto, A., Macharia, R., Elashry, M. I., Feist, S. A., Graham, I. R., Foster, H., Yaworsky, P. J., Walsh, F. S., et al. (2009) · Neuromuscular Disorders · doi:10.1016/j.nmd.2009.06.367 · Cited by 95
“Myostatin has been shown to control both muscle fibre number by blocking the proliferation and differentiation of myoblasts and muscle fibre size by maintaining the satellite cells in a quiescent state and inhibiting protein synthesis [13].”
BackgroundTarget genes of myostatin loss-of-function in muscles of late bovine fetuses
Cassar‐Malek, I., Passelaigue, F., Bernard, C., Leger, J. J., & Hocquette, J.-F. J.-F. (2007) · BMC Genomics · doi:10.1186/1471-2164-8-63 · Cited by 96
“Examination of the molecular action of myostatin has revealed that it inhibits the proliferation of myogenic cells through the control of cell cycle progression [13].”
Genes and the ageing muscle: a review on genetic association studies
Garatachea, N., & Lucía, A. (2011) · AGE · doi:10.1007/s11357-011-9327-0 · Cited by 102
“The latter results in intracellular activation of the SMAD pathway, through which myostatin induces myoblast proliferation (Thomas et al. 2000) and differentiation (Rios et al.”
BackgroundCRISPR /Cas9‐mediated MSTN disruption and heritable mutagenesis in goats causes increased body mass
Wang, X., Niu, Y., Zhou, J., Zhu, H., Ma, B., Yu, H., Yan, H., Hua, J., Huang, X., Qu, L., et al. (2018) · Animal Genetics · doi:10.1111/age.12626 · Cited by 86
“Myostatin (MSTN) or growth and differentiation factor 8 (GDF8) is a member of the transforming growth factor-b superfamily that negatively regulates muscle differentiation and growth (McPherron et al. 1997; Thomas et al. 2000).”
The Physiology of Sports Injuries and Repair Processes
Kelc, R., Naranđa, J., Kuhta, M., & Vogrin, M. (2013) · InTech eBooks · doi:10.5772/54234 · Cited by 118
“It inhibits the activity of satellite cells during muscle regeneration due to its control of the movement of macrophages, and also inhibits the multiplication of myoblasts and their differentiation [64].”
BackgroundThe role of satellite cells in muscle hypertrophy
Blaauw, B., & Reggiani, C. (2014) · Journal of Muscle Research and Cell Motility · doi:10.1007/s10974-014-9376-y · Cited by 98
“Besides this direct effect on fiber growth, various reports have shown that myostatin is also a strong repressor of satellite cell activation and myoblast fusion (Langley et al. 2002; Thomas et al. 2000).”
Rodgers, B. D., Weber, G. M., Kelley, K. M., & Levine, M. A. (2003) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00644.2002 · Cited by 89
“Myostatin, a member of this superfamily, specifically inhibits myoblast proliferation via cell-cycle arrest within the G1 and G2 phases and may therefore initiate myoblast differentiation (39, 52).”
BackgroundAndrogens negatively regulate myostatin expression in an androgen-dependent skeletal muscle
Mendler, L., Baka, Z., Kovacs-Simon, A., & László, A. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.07.023 · Cited by 84
Myostatin: a modulator of skeletal-muscle stem cells
Walsh, F. S., & Celeste, A. J. (2005) · Biochemical Society Transactions · doi:10.1042/bst0331513 · Cited by 77
Matsakas, A., Friedel, A., Hertrampf, T., & Diel, P. (2005) · Acta Physiologica Scandinavica · doi:10.1111/j.1365-201x.2005.01406.x · Cited by 77
Garikipati, D. K., & Rodgers, B. D. (2012) · Journal of Endocrinology · doi:10.1530/joe-12-0260 · Cited by 81
“…via free access differentiation (Amthor et al. 2002, 2004, Langley et al. 2002, Rios et al. 2002, Joulia et al. 2003), although the significance of this effect is somewhat controversial as cell cycle arrest is necessary for the initiation of differentiation (Thomas et al. 2000, Rios et al. 2001).”
BackgroundMyogenesis in sheep is altered by maternal feed intake during the peri-conception period
Quigley, S. P., Kleemann, D. O., Kakar, M. A., Owens, J. A., Nattrass, G. S., Maddocks, S., & Walker, S. K. (2004) · Animal Reproduction Science · doi:10.1016/j.anireprosci.2004.11.005 · Cited by 76
“It is known that myf-5 and myostatin regulate muscle cell commitment, proliferation and differentiation (Ott et al., 1991; Thomas et al., 2000; Langley et al., 2002), and their expression can be altered by earlier manipulation of the embryo or its environment (Maxfield et al.”
BackgroundQin, J., Du, R. H., Yang, Y.-Q., Zhang, H., Li, Q., Liu, L., Guan, H., Hou, J., & An, X.-R. (2012) · Research in Veterinary Science · doi:10.1016/j.rvsc.2012.07.018 · Cited by 83
Jeanplong, F., Bass, J., Smith, H., Kirk, S., Kambadur, R., Sharma, M., & Oldham, J. (2003) · Journal of Endocrinology · doi:10.1677/joe.0.1760425 · Cited by 76
“In myogenic cultures, MyoD expression is greatest during G1 of the cell cycle, the point at which differentiation is initiated (Kitzmann et al. 1998), and at which treatment of proliferating cells with myostatin reversibly blocks cell cycle progression via increased p21 (Thomas et al. 2000).”
BackgroundMethodSelf-citationThe TGF-β Signalling Network in Muscle Development, Adaptation and Disease
Chen, J. L., Colgan, T. D., Walton, K. L., Gregorevic, P., & Harrison, C. A. (2016) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-27511-6_5 · Cited by 88
Gentile, M. A., Nantermet, P. V., Vogel, R. L., Phillips, R., Holder, D., Hodor, P., Cheng, C., Dai, H., Freedman, L. P., & Ray, W. J. (2010) · Journal of Molecular Endocrinology · doi:10.1677/jme-09-0048 · Cited by 75
“myostatin (Thomas et al. 2000) and TGF-b (Massague et al.”
BackgroundWenzel, K., Zabojszcza, J., Carl, M., Taubert, S., Lass, A., Harris, C. L., Ho, M., Schulz, H., Hummel, O., Hübner, N., et al. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.9.6219 · Cited by 89
“Its effect on muscle cells includes induction of cell arrest (52, 53) and inhibition of differentiation of myoblasts into myotubes (54).”
BackgroundCao, Y., Zhao, Z., Gruszczynska-Biegala, J., & Zolkiewska, A. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.19.6725-6738.2003 · Cited by 75
“When added ectopically to C2C12 cells, myostatin inhibits both cell proliferation (61) and differentiation (36).”
BackgroundRíos, R., Fernández-Nocelos, S., Carneiro, I., Arce, V. M., & Devesa, J. (2004) · Endocrinology · doi:10.1210/en.2003-1166 · Cited by 75
“Myostatin exerts several effects on muscle cells, including induction of cell arrest (11, 12, 15) (also, see Ref.”
Weikard, R., Altmaier, E., Suhre, K., Weinberger, K. M., Hammon, H. M., Albrecht, E., Setoguchi, K., Takasuga, A., & Kühn, C. (2010) · Physiological Genomics · doi:10.1152/physiolgenomics.00120.2010 · Cited by 88
“Myostatin is a well-characterized inhibitor of the myoblast terminal differentiation (29, 41) and myogenic cell proliferation (50).”
BackgroundNegative Auto-Regulation of Myostatin Expression is Mediated by Smad3 and MicroRNA-27
McFarlane, C., Vajjala, A., Harikumar, A., Lokireddy, S., Ge, X., Bonala, S., Manickam, R., Kambadur, R., & Sharma, M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0087687 · Cited by 85
“Analysis has revealed that Mstn is a profound negative regulator of muscle growth; while inactivation or mutation of the Mstn gene leads to increased skeletal muscle mass [1,4], enhanced myoblast proliferation [5], differentiation [6] and improved skeletal muscle regeneration [7], increased levels of Mstn result in se…”
BackgroundSelf-citationAnti-inflammatory drugs for Duchenne muscular dystrophy: focus on skeletal muscle-releasing factors
Aoki, Y., Miyatake, S., Shimizu‐Motohashi, Y., & Takeda, S. (2016) · Drug Design Development and Therapy · doi:10.2147/dddt.s110163 · Cited by 85
“Myostatin, a member of TGF-β family, is a negative regulator of skeletal muscle growth 102,103 and is produced predominantly in muscle and blood.”
Wilborn, C. D., Taylor, L. W., Campbell, B. I., Kerksick, C., Rasmussen, C. J., Greenwood, M., & Kreider, R. B. (2006) · Journal of the International Society of Sports Nutrition · doi:10.1186/1550-2783-3-2-19 · Cited by 73
Inhibiting myostatin reverses muscle fibrosis through apoptosis
Li, Z. B., Zhang, J., & Wagner, K. R. (2012) · Journal of Cell Science · doi:10.1242/jcs.090365 · Cited by 86
“Genetic loss or pharmacological inhibition of myostatin results in muscle growth, at least in part through disinhibition of muscle progenitor cells (McCroskery et al., 2003; McPherron et al., 1997; Thomas et al., 2000; Wagner, 2005).”
BackgroundHoward, E. E., Pasiakos, S. M., Fussell, M. A., & Rodriguez, N. R. (2020) · Advances in Nutrition · doi:10.1093/advances/nmaa015 · Cited by 66
“Myostatin has been shown to negatively regulate muscle growth in vivo (85), through stimulation of MPB and inhibition of myogenesis (86, 87).”
BackgroundNebo, C., Portella, M. C., Carani, F. R., de Almeida, F. L. A., Padovani, C. R., Carvalho, R. F., & Dal‐Pai‐Silva, M. (2013) · Comparative Biochemistry and Physiology Part B Biochemistry and Molecular Biology · doi:10.1016/j.cbpb.2013.02.003 · Cited by 78
“Many studies have investigated the actions of myostatin in skeletal muscle development and growth and have shown that myostatin inhibits satellite cell proliferation by activating the cyclin-dependent kinase inhibitor p21, which forces withdrawal from the cell cycle (Thomas et al., 2000).”
BackgroundLow muscle glycogen concentration does not suppress the anabolic response to resistance exercise
Camera, D. M., West, D. W. D., Burd, N. A., Phillips, S. M., Garnham, A. P., Hawley, J. A., & Coffey, V. G. (2012) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00395.2012 · Cited by 72
“Muscle atrophy F-Box (MAFbx; also known as atrogin-1) belongs to the ubiquitin proteasome pathway involved in tagging contractile protein for degradation by cellular proteosomes (4, 18), whereas myostatin is a putative negative regulator of muscle growth (41).”
BackgroundMyostatin expression during development and chronic stress in zebrafish (Danio rerio)
Vianello, S., Brazzoduro, L., Valle, L. D., Belvedere, P., & Colombo, L. (2003) · Journal of Endocrinology · doi:10.1677/joe.0.1760047 · Cited by 72
Muscle cell‐derived cytokines in skeletal muscle regeneration
Waldemer, R. J., Kim, D., & Chen, J. (2022) · FEBS Journal · doi:10.1111/febs.16372 · Cited by 86
Muscle Wasting in Chronic Kidney Disease: Mechanism and Clinical Implications—A Narrative Review
Cheng, T.-C., Huang, S.-H., Kao, C., & Hsu, P. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23116047 · Cited by 100
“Previous studies have shown that myostatin can inhibit myoblast proliferation [67] and differentiation [68], and block the activation and self-renewal of satellite cells [69].”
BackgroundMatsakas, A., Bozzo, C., Cacciani, N., Caliaro, F., Reggiani, C., Mascarello, F., & Patruno, M. (2006) · Experimental Physiology · doi:10.1113/expphysiol.2006.033571 · Cited by 71
“In particular, it has been characterized as a potent negative skeletal muscle growth factor (McPherron et al. 1997), which inhibits satellite cell activation (McCroskery et al. 2003), myoblast proliferation (Thomas et al. 2000) and myogenic differentiation in vitro (Rios et al. 2002).”
BackgroundRoffe, S., Hagai, Y., Pines, M., & Halevy, O. (2010) · Experimental Cell Research · doi:10.1016/j.yexcr.2010.01.003 · Cited by 75
Regulation of myogenic differentiation in the developing limb bud
Francis‐West, P. H., Antoni, L., & Anakwe, K. (2003) · Journal of Anatomy · doi:10.1046/j.1469-7580.2003.00136.x · Cited by 83
“Myostatin is expressed by the developing muscles themselves and negatively regulates myogenic proliferation (Thomas et al. 2000).”
BackgroundLinkage of myostatin pathway genes with knee strength in humans
Huygens, W., Thomis, M. A., Peeters, M., Aerssens, J., Janssen, R. G. J. H., VLIETINCK, R. F., & Beunen, G. P. (2004) · Physiological Genomics · doi:10.1152/physiolgenomics.00224.2003 · Cited by 76
“As economic implications of myostatin on muscle growth for the cattle-breeding industry are obvious, many studies on animals have been performed and have unraveled the physiological pathway (16, 18, 26, 30, 31), although not all interactions with other muscle regulatory proteins are known.”
de Almeida, F. L. A., Pessotti, N. S., Pinhal, D., Padovani, C. R., Leitão, N., Carvalho, R. F., Martins, C., Portella, M. C., & Dal‐Pai‐Silva, M. (2010) · Micron · doi:10.1016/j.micron.2010.06.012 · Cited by 83
A secreted factor represses cell proliferation inDictyostelium
Brock, D. A., & Gomer, R. H. (2005) · Development · doi:10.1242/dev.02032 · Cited by 70
“Myostatin negatively regulates myoblast proliferation, and this negative feedback maintains the amount of muscle in the body (Thomas et al., 2000).”
BackgroundMiroshnychenko, O., Chang, W., & Dragoo, J. L. (2016) · The American Journal of Sports Medicine · doi:10.1177/0363546516677547 · Cited by 76
Salehian, B., Mahabadi, V., Bilas, J., Taylor, W. E., & Ma, K. (2006) · Metabolism · doi:10.1016/j.metabol.2006.05.009 · Cited by 69
“Myostatin protein is a negative regulator of muscle mass expressed predominantly in type II muscle fibers (fast twitch) and secreted in the blood [14,15], which directly inhibits muscle precursor myoblast cell proliferation [7,8] and differentiation [16,17].”
BackgroundInfluentialStadler, G., Chen, J. C. J., Wagner, K. R., Robin, J. D., Shay, J. W., Emerson, C. P., & Wright, W. E. (2011) · Skeletal Muscle · doi:10.1186/2044-5040-1-12 · Cited by 75
“One candidate for this inhibitory activity is myostatin, which has been shown to be expressed by both skeletal-muscle fibroblasts and myoblasts [31], and to inhibit proliferation of myoblasts [32].”
BackgroundMyostatin inhibits proliferation but not differentiation of trout myoblasts
Seiliez, I., Sabin, N., & Gabillard, J. (2011) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2011.12.011 · Cited by 78
Molecular mechanism of size control in development and human diseases
Yang, X., & Xu, T. (2011) · Cell Research · doi:10.1038/cr.2011.63 · Cited by 74
Myostatin signals through miR-34a to regulate Fndc5 expression and browning of white adipocytes
Ge, X., Sathiakumar, D., Lua, B. J. G., Kukreti, H., Lee, M., & McFarlane, C. (2017) · International Journal of Obesity · doi:10.1038/ijo.2016.110 · Cited by 66
Myostatin Is a Human Placental Product That Regulates Glucose Uptake
Mitchell, M. D., Osepchook, C. C., Leung, K.-C., McMahon, C. D., & Bass, J. J. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2361 · Cited by 67
Self-citationMyostatin: Basic biology to clinical application
Esposito, P. B., Picciotto, D., Battaglia, Y., Costigliolo, F., Viazzi, F. C., & Verzola, D. (2022) · Advances in clinical chemistry · doi:10.1016/bs.acc.2021.09.006 · Cited by 83
Moghadaszadeh, B., Albrechtsen, R., Guo, L. T., Zaik, M., Kawaguchi, N., Borup, R., Kronqvist, P., Schroder, H. D., Davies, K. E., Voït, T., et al. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg264 · Cited by 77
“Moreover, myogenic factors, myogenin, myoD, and myf-6 showed increased expression in TG compared with LC, whereas expression of myostatin, which inhibits muscle cell proliferation (32), was lower in TG than in LC.”
BackgroundThe role of sex steroid hormones in the pathophysiology and treatment of sarcopenia
Kim, Y. J., Tamadon, A., Park, H. T., Kim, H., & Ku, S. (2016) · Osteoporosis and Sarcopenia · doi:10.1016/j.afos.2016.06.002 · Cited by 90
“[209] Thomas M, Langley B, Berry C, Sharma M, Kirk S, Bass J, et al.”
BackgroundLi, Z., Shelton, G. D., & Engvall, E. (2005) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)62271-7 · Cited by 74
Cellular and molecular regulation of muscle growth and development in meat animals1,2
Dayton, W. R., & White, M. E. (2008) · Journal of Animal Science · doi:10.2527/jas.2007-0456 · Cited by 70
Coogan, M. P., Alston, V. N., Su, B., Khalil, K. M., Elaswad, A., Khan, M. G. Q., Simora, R. M. C., Johnson, A., Xing, D., Li, S., et al. (2022) · Aquaculture · doi:10.1016/j.aquaculture.2022.738290 · Cited by 65
Berry, C., Thomas, M., Langley, B. C., Sharma, M., & Kambadur, R. (2002) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00458.2001 · Cited by 75
“This is consistent with our previous observation (13).”
BackgroundMethodResultSelf-citationSato, F., Kurokawa, M., Yamauchi, N., & Hattori, M. (2006) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00543.2005 · Cited by 69
“In studies using primary myoblast cultures (34), the 26-kDa GDF-8 was also not detected in cell extracts.”
BackgroundInfluentialThe K153R Polymorphism in the Myostatin Gene and Muscle Power Phenotypes in Young, Non-Athletic Men
Santiago, C., Ruiz, J. R., Rodríguez-Romo, G., Fiuza-Luces, C., Yvert, T., Gonzalez-Freire, M., Gómez-Gallego, F., Morán, M., & Lucia, A. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016323 · Cited by 63
“The latter results in intracellular activation the SMAD pathway, through which myostatin induces myoblast proliferation [13] and differentiation [14], and thus muscle mass [15].”
BackgroundFollistatin: A Novel Therapeutic for the Improvement of Muscle Regeneration
Yaden, B. C., Croy, J. E., Wang, Y., Wilson, J. M., Datta‐Mannan, A., Shetler, P. K., Milner, A., Bryant, H. U., Andrews, J., Dai, G., et al. (2014) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.113.211169 · Cited by 65
“FST proteins were found to associate with Gdf8 in the serum and were later demonstrated to antagonize Gdf8mediated inhibition of myogenesis (Thomas et al., 2000; Hill et al., 2002).”
BackgroundGomer, R. H. (2001) · Nature Reviews Molecular Cell Biology · doi:10.1038/35048058 · Cited by 64
“Myostatin negatively regulates myoblast proliferation, and this negative feedback maintains the amount of muscle in the bod”
Goh, B. C., Singhal, V., Herrera, A. J., Tomlinson, R. E., Kim, S., Faugere, M.-C., Germain-Lee, E. L., Clemens, T. L., Lee, S.-J., & DiGirolamo, D. J. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.782128 · Cited by 63
“In each of these genetic and pharmacologic models, the anabolic effects on muscle are achieved by inhibition of the inhibitory effect of myostatin on myoblast proliferation (21, 22) and terminal differentiation (23).”
BackgroundZhang, C., Liu, Y., Xu, D.-Q., Wen, Q., Li, X. O., Zhang, W., & Yang, L. (2011) · Molecular Biology Reports · doi:10.1007/s11033-011-1071-0 · Cited by 63
“Myostatin is a negative growth factor that inhibits both the terminal differentiation of myoblasts and the proliferation of myogenic cells [6, 7, 9].”
BackgroundAsaduzzaman, M., Ikeda, D., Abol-Munafi, A. B., Bulbul, M., Ali, M. E., Kinoshita, S., Watabe, S., & Kader, M. A. (2016) · Aquaculture · doi:10.1016/j.aquaculture.2016.10.033 · Cited by 63
“Myostatin, a member of the transforming growth factor-β superfamily, is expressed predominantly in skeletal muscle of fish and the downstream function is to prevent the progression of myogenic cells into the cell division cycle (Thomas et al., 2000).”
BackgroundDeletion of mstna and mstnb impairs the immune system and affects growth performance in zebrafish
Wang, C., Chen, Y., Bian, W.-P., Xie, S., Qi, G.-L., Liu, L., Strauss, P. R., Zou, J., & Pei, D. (2017) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2017.11.040 · Cited by 67
Principles of the activin receptor signaling pathway and its inhibition
Lodberg, A. (2021) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2021.04.001 · Cited by 62
Sexual dimorphism is associated with decreased expression of processed myostatin in males
McMahon, C. D., Popovic, L., Jeanplong, F., Oldham, J. M., Kirk, S. P., Osepchook, C. C., Wong, K. W. Y., Sharma, M., Kambadur, R., & Bass, J. J. (2003) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00282.2002 · Cited by 61
“5 to 30 kDa, depending on species and posttranslational modifications (6, 13, 21, 22).”
BackgroundSelf-citationGeneration of biallelic knock-out sheep via gene-editing and somatic cell nuclear transfer
Li, H., Wang, G., Hao, Z., Zhang, G., Qing, Y., Liu, S., Qing, L., Pan, W., Chen, L., Liu, G., et al. (2016) · Scientific Reports · doi:10.1038/srep33675 · Cited by 71
Xu, J., Wang, C., Jin, E., Gu, Y., Li, S., & Li, Q. (2017) · Genes & Genomics · doi:10.1007/s13258-017-0643-3 · Cited by 61
“On the contrary, myostatin (MSTN) is a famous negative regulator of muscle growth (Thomas et al. 2000), and the results from our study showed that muscular MSTN was decreased expression in Wei pigs, indicating that MSTN less inhibit muscle growth of Wei pigs than Yorkshire pigs at adult stage.”
ResultSawatari, E., Seki, R., Adachi, T., Hashimoto, H., Uji, S., Wakamatsu, Y., Nakata, T., & Kinoshita, M. (2009) · Comparative Biochemistry and Physiology Part A Molecular & Integrative Physiology · doi:10.1016/j.cbpa.2009.10.030 · Cited by 69
Myostatin protein and RNA transcript levels in adult and developing brook trout
Roberts, S., & Goetz, F. W. (2003) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2003.09.002 · Cited by 62
“There are numerous reports of the active MSTN protein in mammals ranging in size from 26 to 30 kDa (Gonzalez-Cadavid et al., 1998; Lalani et al., 2000; Sakuma et al., 2000; Sharma et al., 1999; Taylor et al., 2001; Thomas et al., 2000).”
BackgroundExercise and the control of muscle mass in human
Francaux, M., & Deldicque, L. (2018) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-018-2217-x · Cited by 77
“Myostatin inhibits proliferation through an upregulation of p21 and decreases in the levels of both cyclindependent kinase 2 and phosphorylated Rb, resulting in cell cycle inhibition [147].”
BackgroundKim, W. K., Choi, H.-R., Park, S. G., Ko, Y., Bae, K., & Lee, S. C. (2011) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2011.11.004 · Cited by 63
“…growth factor- (TGF- ) superfamily and conrol embryonic development and differentiation (Chen et al., 2004). yostatin, another member of the TGF- superfamily, shows wellefined inhibition of myoblast proliferation and differentiation Joulia et al., 2003; Langley et al., 2002; Thomas et al., 2000).”
BackgroundKonopka, A. R., Wolff, C. A., Suer, M. K., & Harber, M. P. (2018) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00030.2018 · Cited by 59
Muscle regeneration through myostatin inhibition
Wagner, K. R. (2005) · Current Opinion in Rheumatology · doi:10.1097/01.bor.0000184163.61558.ca · Cited by 65
Myokines: Metabolic regulation in obesity and type 2 diabetes
Chen, Z.-T., Weng, Z.-X., Lin, J. D., & Meng, Z.-X. (2024) · Life Metabolism · doi:10.1093/lifemeta/loae006 · Cited by 58
“MSTN also inhibits the progression of cell cycles in resident muscle myoblasts [110, 111].”
Myostatin Suppression of Akirin1 Mediates Glucocorticoid-Induced Satellite Cell Dysfunction
Dong, Y., Pan, J. S., & Zhang, L. (2013) · PLoS ONE · doi:10.1371/journal.pone.0058554 · Cited by 58
Biga, P. R., & Meyer, J. (2009) · Comparative Biochemistry and Physiology Part A Molecular & Integrative Physiology · doi:10.1016/j.cbpa.2009.07.023 · Cited by 58
Lack of Smad3 signaling leads to impaired skeletal muscle regeneration
Ge, X., Vajjala, A., McFarlane, C., Wahli, W., Sharma, M., & Kambadur, R. (2012) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00113.2012 · Cited by 63
Self-citationYeh, Y.-C., Kinoshita, M., Ng, T. H., Chang, Y.-H., Maekawa, S., Chiang, Y.-A., Aoki, T., & Wang, H. (2017) · Scientific Reports · doi:10.1038/s41598-017-09966-9 · Cited by 64
Myostatin: a therapeutic target for skeletal muscle wasting
Roth, S. M., & Walsh, S. (2004) · Current Opinion in Clinical Nutrition and Metabolic Care · doi:10.1097/00075197-200405000-00004 · Cited by 58
Numb-deficient satellite cells have regeneration and proliferation defects
George, R. M., Biressi, S., Beres, B. J., Rogers, E., Mulia, A. K., Allen, R. E., Rawls, A., Rando, T. A., & Wilson-Rawls, J. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1311628110 · Cited by 57
Weigert, C., Lehmann, R., Hartwig, S., & Lehr, S. (2014) · PROTEOMICS – Clinical Applications · doi:10.1002/prca.201300094 · Cited by 57
“Quantitative LC-ESI-MS/MS analysis indicated that especially myostatin [90] levels correlate with extreme obesity (threefold increase) and the severity of insulin resistance.”
Zhang, L., Zhang, H. J., Wang, J., Wu, S., Qiao, X., Yue, H., Yao, J. H., & Qi, G. (2013) · animal · doi:10.1017/s1751731113001882 · Cited by 67
Shi, L., Zhou, B., Li, P., Schinckel, A. P., Liang, T., Wang, H., Li, H., Fu, L., Chu, Q., & Huang, R. (2015) · Cellular Signalling · doi:10.1016/j.cellsig.2015.05.001 · Cited by 59
Proteolytic processing of myostatin is auto-regulated during myogenesis
McFarlane, C., Langley, B., Thomas, M., Hennebry, A., Plummer, E., Nicholas, G., McMahon, C., Sharma, M., & Kambadur, R. (2005) · Developmental Biology · doi:10.1016/j.ydbio.2005.03.039 · Cited by 57
“During the active proliferation phase of myoblast growth, myostatin negatively regulates the G1 to S phase transition of the cell cycle through both Rb dependent and independent pathways (Langley et al., 2004; Thomas et al., 2000).”
BackgroundMethodSelf-citationRegulation of tendon and ligament differentiation
Nakamichi, R., & Asahara, H. (2020) · Bone · doi:10.1016/j.bone.2020.115609 · Cited by 56
“Myostatin is expressed in muscle cells during embryogenesis, acts as a negative regulator of muscle mass [62], and suppresses proliferation of myoblasts and Satellite cells [63,64].”
BackgroundLiu, L., Hu, R., You, H., Li, J., Liu, Y., Li, Q., Wu, X., Huang, J., Cai, X., Wang, M., et al. (2021) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.16238 · Cited by 62
Myostatin inhibits rhabdomyosarcoma cell proliferation through an Rb-independent pathway
Langley, B. C., Thomas, M., McFarlane, C., Gilmour, S., Sharma, M., & Kambadur, R. (2004) · Oncogene · doi:10.1038/sj.onc.1207144 · Cited by 69
“Flowcytometric analysis previously performed on normal C2C12 myoblasts treated with myostatin showed a significant reduction of cells in the S phase and an accumulation of cells in the G1- and G1/M-phases of the cell cycle (Thomas et al., 2000).”
BackgroundMethodResultSelf-citationNovel Intriguing Strategies Attenuating to Sarcopenia
Sakuma, K., & Yamaguchi, A. (2012) · Journal of Aging Research · doi:10.1155/2012/251217 · Cited by 69
Negaresh, R., Ranjbar, R., Baker, J., Habibi, A., Mokhtarzade, M., Gharibvand, M., & Fokin, A. (2019) · International Journal of Preventive Medicine · doi:10.4103/ijpvm.ijpvm_310_17 · Cited by 66
“International Journal of Preventive Medicine 2019, 10: 29 5 regulating myoblast proliferation.[30] In our data, we observed no significant difference between groups at baseline level for MSTN.”
Novel insights into the complex architecture of osteoporosis molecular genetics
Saad, F. A. (2019) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.14231 · Cited by 58
The role of TGF-β signaling in muscle atrophy, sarcopenia and cancer cachexia
Lan, X., Deng, C., Wang, Q., Zhao, L., Jiao, B., & Xiang, Y. (2024) · General and Comparative Endocrinology · doi:10.1016/j.ygcen.2024.114513 · Cited by 66
Wen, X., Wu, J., Chang, J. S., Zhang, P., Wang, J., Zhang, Y., Gettys, T. W., & Zhang, Y. (2014) · BioMed Research International · doi:10.1155/2014/402175 · Cited by 61
“Myostatin is a negative regulator of muscle growth and functions by inhibiting myoblast proliferation [28].”
BackgroundAsaduzzaman, M., Sofia, E., Shakil, A., Hoque, N. F., Khan, M. N. A., Ikeda, D., Kinoshita, S., & Abol‐Munafi, A. B. (2017) · Aquaculture Reports · doi:10.1016/j.aqrep.2017.12.001 · Cited by 55
Akirin1 (Mighty), a novel promyogenic factor regulates muscle regeneration and cell chemotaxis
Salerno, M. S., Dyer, K. A., Bracegirdle, J., Platt, L., Thomas, M., Siriett, V., Kambadur, R., & Sharma, M. (2009) · Experimental Cell Research · doi:10.1016/j.yexcr.2009.04.014 · Cited by 54
Self-citationSatellite cells and their regulation in livestock
Gonzalez, M. L., Busse, N. I., Waits, C. M., & Johnson, S. (2020) · Journal of Animal Science · doi:10.1093/jas/skaa081 · Cited by 60
Antimyostatin Treatment in Health and Disease: The Story of Great Expectations and Limited Success
Nielsen, T. L., Vissing, J., & Krag, T. O. B. (2021) · Cells · doi:10.3390/cells10030533 · Cited by 61
“Smad2/3 binds to Smad4 and the complex translocates to the nucleus [29], where muscle regulatory factors MyoD, Myf5 and Myogenin are repressed [30], preventing myoblast proliferation [31] and differentiation [30].”
Nutrient supply enhances both IGF-I and MSTN mRNA levels in chicken skeletal muscle
Guernec, A., Chevalier, B. A. M., & Duclos, M. J. M. J. (2003) · Domestic Animal Endocrinology · doi:10.1016/j.domaniend.2003.10.001 · Cited by 53
“Other paracrine regulators, such as IGF-II or myostatin (MSTN), a specific inhibitor of muscle growth [5–7] which acts both on muscle cell proliferation [8,9] and differentiation [10–13], could also contribute.”
Background
Metadata
- Authors
- Thomas, M., Langley, B., Berry, C., Sharma, M., Kirk, S., Bass, J., & Kambadur, R.
- Affiliations
- AgResearch (NZ)
- Corresponding author
- Kambadur, Ravi
- ORCID
- Langley, Brett
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2000-12
- Volume
- 275
- Issue
- 51
- Pages
- 40235-40243
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2128303661
- Semantic Scholar
- 1d23c762e638a24e032fb334a031fafce76bc3ab
- Cited by
- 1,014
- References
- 34
- Citations by year
- 2026: 17 · 2025: 31 · 2024: 21 · 2023: 33 · 2022: 35 · 2021: 39 · 2020: 33 · 2019: 37 · 2018: 33 · 2017: 40 · 2016: 46 · 2015: 38 · 2014: 52 · 2013: 58 · 2012: 55
- FWCI
- 8.91
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 7240 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Muscle Physiology and Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Developmental Biology and Gene Regulation
- Keywords
- myostatin, myoblast proliferation, muscle growth, myogenesis, G1 cell cycle arrest, p21, CDK2, retinoblastoma protein, C2C12 myoblasts, TGF-beta superfamily, muscle precursor cells
- MeSH terms
- Animals, Base Sequence, Cattle, Cell Cycle, Cell Division, Cells, Cultured, Hydrolysis, Phosphorylation, Retinoblastoma Protein, Transforming Growth Factor beta, DNA Primers, Muscle, Skeletal, Myostatin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.